Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Number of holders
-
420
-
Total 13F shares, excl. options
-
112,006,374
-
Shares change
-
+466,285
-
Total reported value, excl. options
-
$18,989,908,067
-
Value change
-
+$63,928,357
-
Put/Call ratio
-
77%
-
Number of buys
-
206
-
Number of sells
-
-163
-
Price
-
$169.58
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2021
493 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2021.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 420 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112,006,374 shares
of 131,516,365 outstanding shares and own 85.17% of the company stock.
Largest 10 shareholders include FMR LLC (17,940,020 shares), VANGUARD GROUP INC (10,702,771 shares), BAILLIE GIFFORD & CO (10,616,751 shares), BlackRock Inc. (7,671,402 shares), WELLINGTON MANAGEMENT GROUP LLP (6,844,430 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,535,368 shares), Dodge & Cox (5,431,068 shares), JPMORGAN CHASE & CO (2,972,085 shares), STATE STREET CORP (2,850,389 shares), and RTW INVESTMENTS, LP (1,975,879 shares).
This table shows the top 420 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.